Zobrazeno 1 - 10
of 33
pro vyhledávání: '"third vaccination"'
Publikováno v:
Journal of Laboratory Medicine, Vol 47, Iss 1, Pp 41-45 (2023)
Administration of the third dose of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccine was initiated on December 1, 2021, in Japan. However, data on the long-term effects of this third vaccination remain scarce. Here, we examined th
Externí odkaz:
https://doaj.org/article/d0b3df086fa1421e80e271eee5c4e2e4
Autor:
Kozakai Rikei, Suzuki Susumu, Fukami Kana, Hoshi Kuniko, Izumi Yoshihiko, Takahashi Shinichiro
Publikováno v:
Journal of Laboratory Medicine, Vol 46, Iss 3, Pp 171-177 (2022)
Third dose of SARS-CoV-2 vaccination was started from December 1, 2021 in Japan. However, data on the precise analysis of the side effects after third vaccination, remain scarce. Here, we examined the side effects and the levels of SARS-CoV-2 IgG ant
Externí odkaz:
https://doaj.org/article/7435aba02ff2426a95650eac28edfeef
Autor:
Andreas Heinzel, Eva Schrezenmeier, Florina Regele, Karin Hu, Lukas Raab, Michael Eder, Christof Aigner, Rhea Jabbour, Constantin Aschauer, Ana-Luisa Stefanski, Thomas Dörner, Klemens Budde, Roman Reindl-Schwaighofer, Rainer Oberbauer
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Externí odkaz:
https://doaj.org/article/91da98b5636a45be96c1d5d258eb34b0
Autor:
Enikő Bárczi, Viktória Varga, Alexandra Nagy, Noémi Eszes, Zsuzsanna Jáky‐Kováts, Veronika Müller, Anikó Bohács
Publikováno v:
Immunity, Inflammation and Disease, Vol 10, Iss 8, Pp n/a-n/a (2022)
Abstract Introduction Lung transplant recipients (LuTX) represent a vulnerable population for severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Even though many vaccines are already developed, more clinical data need to support effect
Externí odkaz:
https://doaj.org/article/bc0a8ef6e722462fb51d9fb06255baa8
Autor:
Andreas Heinzel, Eva Schrezenmeier, Florina Regele, Karin Hu, Lukas Raab, Michael Eder, Christof Aigner, Rhea Jabbour, Constantin Aschauer, Ana-Luisa Stefanski, Thomas Dörner, Klemens Budde, Roman Reindl-Schwaighofer, Rainer Oberbauer
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
Response to SARS-CoV-2-vaccines in kidney-transplant recipients (KTR) is severely reduced. Heterologous3rd vaccination combining mRNA and vector vaccines did not increase seroconversion at 4 weeks after vaccination, but evolution of antibody levels b
Externí odkaz:
https://doaj.org/article/e1d9ff5f208645ef9b1a599edff0a47e
Autor:
Kosuke Kashiwagi, Keisuke Jimbo, Mitsuyoshi Suzuki, Nobuyasu Arai, Takahiro Kudo, Toshiaki Shimizu
Publikováno v:
Vaccines, Vol 10, Iss 10, p 1618 (2022)
The efficacy of the COVID-19 mRNA vaccine, including the third vaccination in pediatric inflammatory bowel disease (PIBD) patients is not fully understood. This study aimed to evaluate the humoral immunogenicity of the BNT162b2 vaccine and the change
Externí odkaz:
https://doaj.org/article/b89dc94abfb84610b5fd4e4fc91f552f
Autor:
Rieke Reiter, Pia Von Blanckenburg, Reinier Mutters, Julia Thiemer, Reinhard Geßner, Ulf Seifart
Publikováno v:
Vaccines, Vol 10, Iss 5, p 788 (2022)
Emerging numbers of SARS-CoV-2 infections are currently combated with a third vaccination. Considering the different vaccination regimens used for the first two vaccine doses, we addressed whether the previous vaccination influences the immune respon
Externí odkaz:
https://doaj.org/article/08d7fdd9b0804fd4bd122f730ab3a849
Autor:
Stella Rosa Maria Wirth, Klaus Podar, Martin Pecherstorfer, Philipp Wohlfarth, Ulrich Jaeger, Josef Singer
Publikováno v:
Cancers; Volume 15; Issue 2; Pages: 524
Patients with B-cell malignancies are at a higher risk of severe SARS-CoV-2 infections. Nevertheless, extensive data on the immune responses of hematological patients and the efficacy of the third dose of the vaccine are scarce. The goal of this stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20addf6b7acca8d99afc9ea5e8142de5
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.